MarketBeat Instant News Alerts 2 hours agoD-Wave Quantum (NYSE:QBTS) Price Target Raised to $13.00MarketBeatNeedham & Company LLC lifted their price objective on shares of D-Wave Quantum from $8.50 to $13.00 and gave the company a "buy" rating in a research report on Friday.NYSE:QBTSRead D-Wave Quantum (NYSE:QBTS) Price Target Raised to $13.002 hours agoHimax Technologies (NASDAQ:HIMX) Updates Q2 2025 Earnings GuidanceMarketBeatHimax Technologies (NASDAQ:HIMX) updated its second quarter 2025 earnings guidance. The company provided EPS guidance of 0.085-0.115 for the period, compared to the consensus estimate of 0.090. The company also issued revenue guidance of $204.4 millionillion-$221.6 millionillion, compared to the consensus estimate of $207.8 millionillion. NASDAQ:HIMXRead Himax Technologies (NASDAQ:HIMX) Updates Q2 2025 Earnings Guidance2 hours agoBCE (NYSE:BCE) Updates FY 2025 Earnings GuidanceMarketBeatBCE (NYSE:BCE) (TSE:BCE) updated its FY 2025 earnings guidance. The company provided EPS guidance of 1.840-1.950 for the period, compared to the consensus estimate of 2.740. The company also issued revenue guidance of $16.5 billionillion-$17.2 billionillion, compared to the consensus estimate of $24.3 billionillion. NYSE:BCERead BCE (NYSE:BCE) Updates FY 2025 Earnings Guidance2 hours agoLiquidity Services (NASDAQ:LQDT) Updates Q3 2025 Earnings GuidanceMarketBeatLiquidity Services (NASDAQ:LQDT) updated its third quarter 2025 earnings guidance. The company provided EPS guidance of 0.270-0.360 for the period, compared to the consensus estimate of 0.330. NASDAQ:LQDTRead Liquidity Services (NASDAQ:LQDT) Updates Q3 2025 Earnings Guidance2 hours agoStratasys (NASDAQ:SSYS) Issues FY 2025 Earnings GuidanceMarketBeatStratasys (NASDAQ:SSYS) updated its FY 2025 earnings guidance. The company provided EPS guidance of 0.300-0.370 for the period, compared to the consensus estimate of 0.290. NASDAQ:SSYSRead Stratasys (NASDAQ:SSYS) Issues FY 2025 Earnings Guidance2 hours agoLigand Pharmaceuticals (NASDAQ:LGND) Updates FY 2025 Earnings GuidanceMarketBeatLigand Pharmaceuticals (NASDAQ:LGND) updated its FY 2025 earnings guidance. The company provided EPS guidance of 6.000-6.250 for the period, compared to the consensus estimate of 6.110. The company also issued revenue guidance of $180.0 millionillion-$200.0 millionillion, compared to the consensus estimate of $191.3 millionillion. NASDAQ:LGNDRead Ligand Pharmaceuticals (NASDAQ:LGND) Updates FY 2025 Earnings Guidance Trending News1ArrowMark Colorado Holdings LLC Purchases 131,833 Shares of BlackBerry Limited (NYSE:BB)2131,600 Shares in SoundHound AI, Inc. (NASDAQ:SOUN) Acquired by Bulltick Wealth Management LLC3Wolfspeed (NYSE:WOLF) Shares Gap Up - Time to Buy?4Baker BROS. Advisors LP Has $51.48 Million Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP)5Whitecap Resources Inc. Sells 619,983 Shares of Whitecap Resources Inc. (TSE:WCP) Stock6BROOKFIELD Corp ON Boosts Holdings in TC Energy Co. (NYSE:TRP)7Raymond James Financial Inc. Buys Shares of 63,961 AST SpaceMobile, Inc. (NASDAQ:ASTS)8Archer Aviation (ACHR) Projected to Post Quarterly Earnings on Monday All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoTrade Desk (NASDAQ:TTD) Receives Buy Rating from Needham & Company LLCMarketBeatNASDAQ:TTDRead Trade Desk (NASDAQ:TTD) Receives Buy Rating from Needham & Company LLC2 hours agoResearch Analysts Set Expectations for Newmont Q2 EarningsMarketBeatNYSE:NEMRead Research Analysts Set Expectations for Newmont Q2 Earnings2 hours agoSuper Micro Computer, Inc. (NASDAQ:SMCI) Shares Purchased by G2 Investment Partners Management LLCMarketBeatNASDAQ:SMCIRead Super Micro Computer, Inc. (NASDAQ:SMCI) Shares Purchased by G2 Investment Partners Management LLC2 hours agoSarepta Therapeutics (NASDAQ:SRPT) Stock Rating Lowered by Evercore ISIMarketBeatNASDAQ:SRPTRead Sarepta Therapeutics (NASDAQ:SRPT) Stock Rating Lowered by Evercore ISI2 hours agoWolfe Research Downgrades Myriad Genetics (NASDAQ:MYGN) to Peer PerformMarketBeatNASDAQ:MYGNRead Wolfe Research Downgrades Myriad Genetics (NASDAQ:MYGN) to Peer Perform2 hours agoHillenbrand (NYSE:HI) Cut to "Sector Weight" at KeyCorpMarketBeatNYSE:HIRead Hillenbrand (NYSE:HI) Cut to "Sector Weight" at KeyCorp2 hours agoThe Hain Celestial Group (NASDAQ:HAIN) Cut to Market Perform at Sanford C. BernsteinMarketBeatNASDAQ:HAINRead The Hain Celestial Group (NASDAQ:HAIN) Cut to Market Perform at Sanford C. Bernstein2 hours agoGeron (NASDAQ:GERN) Downgraded to Sector Perform Rating by ScotiabankMarketBeatNASDAQ:GERNRead Geron (NASDAQ:GERN) Downgraded to Sector Perform Rating by Scotiabank2 hours agoEnergy Recovery (NASDAQ:ERII) Downgraded by B. Riley to NeutralMarketBeatNASDAQ:ERIIRead Energy Recovery (NASDAQ:ERII) Downgraded by B. Riley to Neutral2 hours agoCompass Diversified (NYSE:CODI) Rating Lowered to Neutral at B. RileyMarketBeatNYSE:CODIRead Compass Diversified (NYSE:CODI) Rating Lowered to Neutral at B. Riley2 hours agoAxalta Coating Systems (NYSE:AXTA) Cut to "Neutral" at JPMorgan Chase & Co.MarketBeatNYSE:AXTARead Axalta Coating Systems (NYSE:AXTA) Cut to "Neutral" at JPMorgan Chase & Co.2 hours agoArcher-Daniels-Midland (NYSE:ADM) Cut to "Underperform" at Bank of AmericaMarketBeatNYSE:ADMRead Archer-Daniels-Midland (NYSE:ADM) Cut to "Underperform" at Bank of America2 hours agoTaboola.com (NASDAQ:TBLA) Upgraded at B. RileyMarketBeatNASDAQ:TBLARead Taboola.com (NASDAQ:TBLA) Upgraded at B. Riley2 hours agoRockwell Automation (NYSE:ROK) Raised to Neutral at JPMorgan Chase & Co.MarketBeatNYSE:ROKRead Rockwell Automation (NYSE:ROK) Raised to Neutral at JPMorgan Chase & Co.2 hours agoOppFi (NYSE:OPFI) Upgraded at Citizens JmpMarketBeatNYSE:OPFIRead OppFi (NYSE:OPFI) Upgraded at Citizens Jmp2 hours agoMosaic (NYSE:MOS) Upgraded to Outperform at Royal Bank of CanadaMarketBeatNYSE:MOSRead Mosaic (NYSE:MOS) Upgraded to Outperform at Royal Bank of Canada2 hours agoInternational Flavors & Fragrances (NYSE:IFF) Upgraded by Barclays to Overweight RatingMarketBeatNYSE:IFFRead International Flavors & Fragrances (NYSE:IFF) Upgraded by Barclays to Overweight Rating2 hours agoCraig Hallum Upgrades Hudson Technologies (NASDAQ:HDSN) to BuyMarketBeatNASDAQ:HDSNRead Craig Hallum Upgrades Hudson Technologies (NASDAQ:HDSN) to Buy2 hours agoCharles River Laboratories International (NYSE:CRL) Upgraded at Evercore ISIMarketBeatNYSE:CRLRead Charles River Laboratories International (NYSE:CRL) Upgraded at Evercore ISI2 hours agoCertara (NASDAQ:CERT) Upgraded to "Overweight" at BarclaysMarketBeatNASDAQ:CERTRead Certara (NASDAQ:CERT) Upgraded to "Overweight" at Barclays2 hours agoBanco Bradesco (NYSE:BBD) Upgraded to "Buy" at Bank of AmericaMarketBeatNYSE:BBDRead Banco Bradesco (NYSE:BBD) Upgraded to "Buy" at Bank of America2 hours agoAmerican States Water (NYSE:AWR) Upgraded at Wells Fargo & CompanyMarketBeatNYSE:AWRRead American States Water (NYSE:AWR) Upgraded at Wells Fargo & Company2 hours agoBMO Capital Markets Cuts Fortinet (NASDAQ:FTNT) Price Target to $110.00MarketBeatNASDAQ:FTNTRead BMO Capital Markets Cuts Fortinet (NASDAQ:FTNT) Price Target to $110.002 hours agoRemitly Global (NASDAQ:RELY) Price Target Raised to $32.00 at Monness Crespi & HardtMarketBeatNASDAQ:RELYRead Remitly Global (NASDAQ:RELY) Price Target Raised to $32.00 at Monness Crespi & Hardt Featured Articles and OffersRocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsBy Ryan Hasson | May 5, 2025View Rocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsWarning echoes from the Great DepressionFrom Weiss Ratings(Ad)View Warning echoes from the Great DepressionWhy Wells Fargo Is Buying $40 Billion of Its Own StockBy Gabriel Osorio-Mazilli | May 6, 2025View Why Wells Fargo Is Buying $40 Billion of Its Own Stock3 Mid-Cap Medical Stocks Outperforming the MarketBy Ryan Hasson | May 6, 2025View 3 Mid-Cap Medical Stocks Outperforming the MarketUPS Stock Forecast: Rebound Underway for United Parcel Service?By Thomas Hughes | May 4, 2025View UPS Stock Forecast: Rebound Underway for United Parcel Service?Here’s How to Claim Your Stake in Elon’s Private Company, xAIFrom Brownstone Research(Ad)View Here’s How to Claim Your Stake in Elon’s Private Company, xAICantor Equity Partners, Inc. Class A Ordinary Shares (NASDAQ:CEP) Sees Strong Trading Volume - Still a Buy?By MarketBeat | May 8, 2025View Cantor Equity Partners, Inc. Class A Ordinary Shares (NASDAQ:CEP) Sees Strong Trading Volume - Still a Buy?Raymond James Financial Inc. Acquires New Holdings in QuantumScape Co. (NYSE:QS)By MarketBeat | May 8, 2025View Raymond James Financial Inc. Acquires New Holdings in QuantumScape Co. (NYSE:QS) Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
